Understanding Patients Perspective on Clinical Research in Indian Population

Download Article

Authors : Kaushal Kapadia



To understand patients’ perspectives on clinical research in India


A questionnaire based survey was conducted in different parts of India, covering all kind of population. Questionnaires were filled with the help of investigators, physicians, social workers, freelancers, research professionals, etc.


India is said to be the hub of clinical research. It is also equivalently important that the population in India are well aware about the basics of clinical research so that individuals are not treated as “guinea pigs” and the research is conducted with full ethics and good clinical practice. The study was undertaken to analyze the perspective and awareness of clinical research amongst Indian population.


There were 20 different parameters/data points for which the data was collected from 6122 patients across the country. As the available data is dichotomous a dynamic analysis was done using a percentile method.


Clinical trials in India are conducted in ethical manner but still the understanding of patients remains ambiguous. The data concludes that awareness about clinical research remains low. Awareness will help us bring new therapies to the market.


Clinical trials, Indian Scenario, Awareness, Patients Perspective, Ethics, Subjects Confidentiality


1.      A.R., C. (n.d.). Clinical trials: present and future in India. Retrieved February 2015, from Pharmainfo.net: http://www.pharmainfo.net

2.      Bhatt, A. (2006). Winds of Change - Evolution of clinical drug trials in India. Pharma Times(38:), pp. 19-20.

3.      Bhatt, A. S. (2004, Feb 26). Indian clinical research odyssey. Pharma Biz(Chronicle specials). Retrieved January 2015, from http://saffron.pharmabiz.com/article/detnews.asp?articleid=20742&sectionid=50

4.      Bindra, S. K. (2010). Survey on perceptions of indian investigators on research ethics. Perceptives in Clinical Research, 1:, 94-7.

5.      Das, N. (n.d.). Outsourcing clinical trials to India. Chillibreeze Solutions Pvt. Ltd. Retrieved February 2015, from http://www.chillibreeze.com

6.      De, M. (2005). India, ideal destination for clinical trials. Curr Sci, 89:597.

7.      Fenn, C. W. (2001). The contemporary situation for the conduct of clinical trials in Asia. Int J Pharm Med(15:), 169-73.

8.      Jayasheel, B. (2010). Issues regarding delay in regulatory approvals carrying out clinical trials in India. Regulatory Affairs Journal Pharma, 1-4.

9.      Moin, D. (2013). Clinical trials and safety reporting under Schedule Y. Retrieved February 2015, from Pharmabiz: http://www.pharmabiz.com.

10.  N., V. (2006, June 1). Conducting clinical trials in Asia. Retrieved February 2015, from http://www.actmagazine.com

11.  Parikh RM, G. M. (2011;). Trend of clinical drug trials in type 2 DM over last decade. Percept Clin Res, 2:, 64-6.

12.  Research and Markets. (2006). India: pharmaceutical and biotechnology opportunities. India: Pharmalicensing Ltd. Retrieved January 2015, from http://www.researchandmarkets.com